Overview of non-Hodgkin's lymphoma: Biology, staging, and treatment

被引:43
作者
Fisher, RI [1 ]
机构
[1] Univ Rochester, Med Ctr, James P Wilmot Canc Ctr, Rochester, NY 14642 USA
关键词
D O I
10.1053/sonc.2003.23797
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:3 / 9
页数:7
相关论文
共 35 条
[1]
[Anonymous], 1975, Br.J.Haematol
[2]
New approach to classifying non-hodgkin's lymphomas: Clinical features of the major histologic subtypes [J].
Armitage, JO ;
Weisenburger, DD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2780-2795
[3]
CANELLOS GP, 1975, BRIT J CANCER, V31, P474
[4]
CARBONE PP, 1971, CANCER RES, V31, P1860
[5]
Chan WC, 1997, BLOOD, V89, P3909
[6]
RANDOMIZED COMPARISON OF MACOP-B WITH CHOP IN PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA [J].
COOPER, IA ;
WOLF, MM ;
ROBERTSON, TI ;
FOX, RM ;
MATTHEWS, JP ;
STONE, JM ;
DING, JC ;
DART, G ;
MATTHEWS, J ;
FIRKIN, FC ;
LOWENTHAL, RM ;
IRONSIDE, P .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :769-778
[7]
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].
Czuczman, MS ;
Grillo-López, AJ ;
White, CA ;
Saleh, M ;
Gordon, L ;
LoBuglio, AF ;
Jonas, C ;
Klippenstein, D ;
Dallaire, B ;
Varns, C .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276
[8]
LONG-TERM FOLLOW-UP OF PATIENTS WITH LOW-GRADE MALIGNANT-LYMPHOMAS TREATED WITH DOXORUBICIN-BASED CHEMOTHERAPY OR CHEMOIMMUNOTHERAPY [J].
DANA, BW ;
DAHLBERG, S ;
NATHWANI, BN ;
CHASE, E ;
COLTMAN, C ;
MILLER, TP ;
FISHER, RI .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :644-651
[9]
Dana BW, 1998, P AN M AM SOC CLIN, V17, p3a
[10]
A CLINICAL ANALYSIS OF 2 INDOLENT LYMPHOMA ENTITIES - MANTLE CELL LYMPHOMA AND MARGINAL ZONE LYMPHOMA (INCLUDING THE MUCOSA-ASSOCIATED LYMPHOID-TISSUE AND MONOCYTOID B-CELL SUBCATEGORIES) - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].
FISHER, RI ;
DAHLBERG, S ;
NATHWANI, BN ;
BANKS, PM ;
MILLER, TP ;
GROGAN, TM .
BLOOD, 1995, 85 (04) :1075-1082